OCM
Osterweis Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-144,461
| Closed | -$4.57M | – | 144 |
|
|
2021
Q1 | $4.57M | Buy |
144,461
+6,480
| +5% | +$205K | 0.25% | 93 |
|
|
2020
Q4 | $6.4M | Sell |
137,981
-19,770
| -13% | -$917K | 0.38% | 75 |
|
|
2020
Q3 | $5.19M | Buy |
157,751
+23,360
| +17% | +$769K | 0.35% | 71 |
|
|
2020
Q2 | $3.69M | Buy |
134,391
+15,970
| +13% | +$438K | 0.27% | 81 |
|
|
2020
Q1 | $3.55M | Sell |
118,421
-19,904
| -14% | -$596K | 0.29% | 67 |
|
|
2019
Q4 | $3.83M | Sell |
138,325
-12,085
| -8% | -$335K | 0.26% | 70 |
|
|
2019
Q3 | $2.74M | Buy |
150,410
+5,030
| +3% | +$91.5K | 0.2% | 76 |
|
|
2019
Q2 | $3.57M | Sell |
145,380
-243,615
| -63% | -$5.97M | 0.25% | 67 |
|
|
2019
Q1 | $3.7M | Buy |
+388,995
| New | +$3.7M | 0.23% | 76 |
|
|
2018
Q4 | – | Sell |
-454,295
| Closed | -$5.11M | – | 107 |
|
|
2018
Q3 | $5.11M | Buy |
+454,295
| New | +$5.11M | 0.33% | 71 |
|